Chester County News and Community Website
WILMINGTON, DE — InterDigital Inc. (Nasdaq: IDCC) has expanded its patent licensing business into electric vehicle charging equipment through a new agreement with KEBA Energy Automation GmbH, extending the company’s …
InterDigital Broadens Patent Licensing With EV Charging Deal Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has granted Medomie Pharma Ltd. exclusive rights to seek regulatory approval and commercialize its skin disease treatment YCANTH in Israel, expanding …
Verrica Expands YCANTH Rights to Israel in Licensing Deal Read More
CHESTERBROOK, PA — Neuraptive Therapeutics has licensed a bioresorbable wireless nerve stimulation technology from Washington University in St. Louis, broadening its portfolio of therapies for peripheral nerve injuries as its …
Neuraptive Expands Nerve Repair Portfolio With Device License Read More
MALVERN, PA — Ocugen Inc. (NASDAQ: OCGN) has signed a binding term sheet that could generate up to $259 million in licensing and sales milestone payments, plus ongoing royalties, as …
Ocugen Targets $259 Million in MENA Licensing Deal for OCU400 Read More WILMINGTON, DE — InterDigital Inc. (Nasdaq: IDCC) has reached a patent licensing agreement with Amazon that covers the technology developer’s intellectual property portfolio across Amazon devices and services, including Prime …
InterDigital Reaches Amazon License Deal, Ends Patent Disputes Read More WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC) signed a new Internet of Things patent licensing agreement with an unnamed fintech company, extending the company’s monetization strategy beyond smartphones into connected …
InterDigital Expands IoT Licensing With Fintech Deal Read More
PHILADELPHIA, PA — Context Therapeutics (Nasdaq: CNTX) amended its licensing agreement with BioAtla (Nasdaq: BCAB) to eliminate future milestone and royalty payments tied to its CT-202 cancer program, a move …
Context Therapeutics Buys Out CT-202 Royalty Obligations Read More
PHILADELPHIA, PA — Aldevron, a unit of Danaher Corporation (NYSE: DHR), and Minaris expanded a licensing agreement tied to lentiviral plasmid manufacturing, deepening a partnership aimed at accelerating development timelines …
Aldevron, Minaris Expand Cell Therapy Supply Pact Read More
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals (NASDAQ: MDGL) licensed a clinical-stage gene-silencing therapy from Arrowhead Pharmaceuticals to expand its pipeline of treatments for metabolic dysfunction-associated steatohepatitis, or MASH, including patients with …
Madrigal Licenses Arrowhead Drug Candidate for MASH Read More WILMINGTON, DE — InterDigital Inc. (Nasdaq: IDCC) has signed a patent license agreement with Buffalo Americas Inc. and separate agreements with a global television manufacturer covering wireless and video technologies.
InterDigital Signs Patent Licensing Agreements With Buffalo, TV Maker Read More